Esther Fasanmi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Texas Southern University College of Pharmacy and Health SciencesBA/BS in Pharmacy, 2014- Texas Southern University College of Pharmacy and Health SciencesPharmD, 2014
Publications & Presentations
PubMed
- 3 citationsLedipasvir/Sofosbuvir Effectively Treats Hepatitis C Virus Infections in an Underserved PopulationRachel A Stewart, Brooke R. MacDonald, Tzu-Chun Chu, Jonathan D. Moore, Esther O. Fasanmi
Digestive Diseases and Sciences. 2018-07-16 - Comparative effectiveness of 8- and 12-week ledipasvir/sofosbuvir regimens for HCV infection.Rohit P. Ojha, Brooke R. MacDonald, Tzu-Chun Chu, Esther O. Fasanmi, Jonathan D. Moore
Antiviral Therapy. 2018-01-01
Journal Articles
- Ledipasvir/Sofosbuvir Effectively Treats Hepatitis C Virus Infections in an Underserved PopulationEsther Fasanmi, Digestive Diseases and Sciences
- Comparative Effectiveness of 8- and 12-Week ledipasvir/sofosbuvir Regimens for HCV InfectionEsther Fasanmi, Antiviral Therapy
Office
1350 S Main St
Suite 1600
Fort Worth, TX 76104Phone+1 817-702-3701Fax+1 817-702-6924
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
